Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sotirios Giannopoulos

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Journal of Diabetes and Its Complications|January 31, 2026
Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysisMaria-Ioanna Stefanou, Anastasios Tentolouris, Evangelos Panagiotopoulos, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysisMaria-Ioanna Stefanou, Lina Palaiodimou, Aristeidis H Katsanos, et al.
European Stroke Journal|February 24, 2024
Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysisMaria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra, et al.
Noro Psikiyatri Arsivi|April 13, 2026
Aquaporin-1 Antibodies in Autoimmune Inflammatory Demyelinating Disorders with Predominant Optic Nerve & Spinal Cord InvolvementErdem Tüzün, Eleni Karachaliou, Maria Pechlivanidou, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Clinical, Cognitive and Demographic Determinants of Work Participation in Multiple Sclerosis: A Multicenter Cross-Sectional StudyKonstantina Stavrogianni, Dimitrios K Kitsos, Evangelia-Makrina Dimitriadou, et al.
Journal of Clinical Medicine|April 26, 2025
Cognitive Impairment in Newly Diagnosed Patients with Multiple Sclerosis: A Systematic Review of Related Molecular Biomarkers and a Meta-Analysis of Associated Demographic and Disease-Related CharacteristicsKonstantina Stavrogianni, Vasileios Giannopapas, Dimitrios K Kitsos, et al.
Biomolecules|August 26, 2022
Plasma P-Tau181 for the Discrimination of Alzheimer's Disease from Other Primary Dementing and/or Movement DisordersJohn S Tzartos, Fotini Boufidou, Christos Stergiou, et al.
Journal of Stroke|October 9, 2019
Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-AnalysisGeorgios Tsivgoulis, Aristeidis H Katsanos, Martin Köhrmann, et al.
Neurology|September 10, 2024
Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke: A National Registry-Based Study and Meta-AnalysisAikaterini Theodorou, Konstantinos Melanis, Eleni Bakola, et al.
International Journal of Molecular Sciences|October 16, 2025
The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and DebatesAthanasia Athanasaki, Ioanna Tsantzali, Aikaterini Theodorou, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Journal of Diabetes and Its Complications|January 31, 2026
Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysisMaria-Ioanna Stefanou, Anastasios Tentolouris, Evangelos Panagiotopoulos, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysisMaria-Ioanna Stefanou, Lina Palaiodimou, Aristeidis H Katsanos, et al.
European Stroke Journal|February 24, 2024
Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysisMaria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra, et al.
Noro Psikiyatri Arsivi|April 13, 2026
Aquaporin-1 Antibodies in Autoimmune Inflammatory Demyelinating Disorders with Predominant Optic Nerve & Spinal Cord InvolvementErdem Tüzün, Eleni Karachaliou, Maria Pechlivanidou, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Clinical, Cognitive and Demographic Determinants of Work Participation in Multiple Sclerosis: A Multicenter Cross-Sectional StudyKonstantina Stavrogianni, Dimitrios K Kitsos, Evangelia-Makrina Dimitriadou, et al.
Journal of Clinical Medicine|April 26, 2025
Cognitive Impairment in Newly Diagnosed Patients with Multiple Sclerosis: A Systematic Review of Related Molecular Biomarkers and a Meta-Analysis of Associated Demographic and Disease-Related CharacteristicsKonstantina Stavrogianni, Vasileios Giannopapas, Dimitrios K Kitsos, et al.
Biomolecules|August 26, 2022
Plasma P-Tau181 for the Discrimination of Alzheimer's Disease from Other Primary Dementing and/or Movement DisordersJohn S Tzartos, Fotini Boufidou, Christos Stergiou, et al.
Journal of Stroke|October 9, 2019
Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-AnalysisGeorgios Tsivgoulis, Aristeidis H Katsanos, Martin Köhrmann, et al.
Neurology|September 10, 2024
Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke: A National Registry-Based Study and Meta-AnalysisAikaterini Theodorou, Konstantinos Melanis, Eleni Bakola, et al.
International Journal of Molecular Sciences|October 16, 2025
The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and DebatesAthanasia Athanasaki, Ioanna Tsantzali, Aikaterini Theodorou, et al.
Pageof 16